N. Nora Yang

1.0k total citations
22 papers, 563 citations indexed

About

N. Nora Yang is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, N. Nora Yang has authored 22 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in N. Nora Yang's work include Muscle Physiology and Disorders (11 papers), Virus-based gene therapy research (9 papers) and CRISPR and Genetic Engineering (4 papers). N. Nora Yang is often cited by papers focused on Muscle Physiology and Disorders (11 papers), Virus-based gene therapy research (9 papers) and CRISPR and Genetic Engineering (4 papers). N. Nora Yang collaborates with scholars based in United States, Canada and New Zealand. N. Nora Yang's co-authors include Chady H. Hakim, Dongsheng Duan, Xiufang Pan, Yongping Yue, Kasun Kodippili, Nalinda B. Wasala, Keqing Zhang, Gang Yao, Shi‐Jie Chen and H. T. Yang and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Scientific Reports.

In The Last Decade

N. Nora Yang

21 papers receiving 557 citations

Peers

N. Nora Yang

GENET

CCM

PHYSI

SURGE

Nicholas P. Clayton United States

Frances Lloyd Australia

Kumaran Chandrasekharan United States

Fatima Amor France

Violeta Stoyanova‐Beninska Netherlands

Erik A. Toso United States

Hiba Komati Canada

Ming J. Cheng United States

Tushar Menon United States

Nicholas P. Clayton United States

N. Nora Yang

318 ×0.7

194 ×0.9

GENET

89 ×0.9

CCM

66 ×0.9

PHYSI

52 ×1.1

SURGE

Citations per year, relative to N. Nora Yang N. Nora Yang (= 1×) peers Nicholas P. Clayton

Countries citing papers authored by N. Nora Yang

Since Specialization

Citations

This map shows the geographic impact of N. Nora Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Nora Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Nora Yang more than expected).

Fields of papers citing papers by N. Nora Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Nora Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Nora Yang. The network helps show where N. Nora Yang may publish in the future.

Co-authorship network of co-authors of N. Nora Yang

This figure shows the co-authorship network connecting the top 25 collaborators of N. Nora Yang. A scholar is included among the top collaborators of N. Nora Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Nora Yang. N. Nora Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Xiaodong, Kunchi Zhang, Bo Li, et al.. (2025). Mechanistic insights into the role of EGLN3 in pulmonary vascular remodeling and endothelial dysfunction. Respiratory Research. 26(1). 61–61.

Hakim, Chady H., et al.. (2021). Extensor carpi ulnaris muscle shows unexpected slow-to-fast fiber-type switch in Duchenne muscular dystrophy dogs. Disease Models & Mechanisms. 14(12). 9 indexed citations

Pecháň, Peter, et al.. (2021). Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing. Human Gene Therapy. 32(15-16). 850–861. 20 indexed citations

Hakim, Chady H., Nathalie Clément, H. T. Yang, et al.. (2020). Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease. Molecular Therapy — Methods & Clinical Development. 18. 664–678. 12 indexed citations

White, Zoe, Chady H. Hakim, Marine Théret, et al.. (2020). High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia. Journal of clinical lipidology. 14(4). 459–469.e0. 19 indexed citations

Hakim, Chady H., et al.. (2019). Systemic Delivery of Adeno-Associated Viral Vectors in Mice and Dogs. Methods in molecular biology. 1937. 281–294. 6 indexed citations

Hakim, Chady H., Nalinda B. Wasala, Yongping Yue, et al.. (2019). AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice. Molecular Therapy. 27(9). 1568–1585. 54 indexed citations

Hakim, Chady H., et al.. (2019). An improved method for studying mouse diaphragm function. Scientific Reports. 9(1). 19453–19453. 16 indexed citations

Wasala, Nalinda B., Chady H. Hakim, Shi‐Jie Chen, N. Nora Yang, & Dongsheng Duan. (2019). Questions Answered and Unanswered by the First CRISPR Editing Study in a Canine Model of Duchenne Muscular Dystrophy. Human Gene Therapy. 30(5). 535–543. 11 indexed citations

10.

Hakim, Chady H., et al.. (2018). Automatic characterization of stride parameters in canines with a single wearable inertial sensor. PLoS ONE. 13(6). e0198893–e0198893. 11 indexed citations

11.

Hakim, Chady H., Nalinda B. Wasala, Christopher E. Nelson, et al.. (2018). AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice. JCI Insight. 3(23). 82 indexed citations

12.

Hakim, Chady H., Nalinda B. Wasala, Xiufang Pan, et al.. (2017). A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy. Molecular Therapy — Methods & Clinical Development. 6. 216–230. 76 indexed citations

13.

Xu, Xin, Amy Q. Wang, Lea Latham, et al.. (2017). Safety, pharmacokinetics and sialic acid production after oral administration of N -acetylmannosamine (ManNAc) to subjects with GNE myopathy. Molecular Genetics and Metabolism. 122(1-2). 126–134. 44 indexed citations

14.

Hakim, Chady H., et al.. (2017). Nanotherapy for Duchenne muscular dystrophy. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 10(2). 20 indexed citations

15.

Kodippili, Kasun, Chady H. Hakim, Xiufang Pan, et al.. (2017). Dual AAV Gene Therapy for Duchenne Muscular Dystrophy with a 7-kb Mini-Dystrophin Gene in the Canine Model. Human Gene Therapy. 29(3). 299–311. 63 indexed citations

16.

Krishnan, Venkatesh, Yanfei Li, Catherine Z. Chen, et al.. (2017). Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism. British Journal of Pharmacology. 175(2). 262–271. 13 indexed citations

17.

Brooks, Philip J., N. Nora Yang, & Christopher P. Austin. (2016). Gene Therapy: The View from NCATS. Human Gene Therapy. 27(1). 7–13. 14 indexed citations

18.

Zhao, Junling, Kasun Kodippili, Yongping Yue, et al.. (2016). Dystrophin contains multiple independent membrane-binding domains. Human Molecular Genetics. 25(17). 3647–3653. 44 indexed citations

19.

Shi, Yifan, Xin Xu, Michael Zhang, et al.. (2015). Quantitative hydrophilic interaction chromatography–mass spectrometry analysis of N-acetylneuraminic acid and N-acetylmannosamine in human plasma. Journal of Chromatography B. 1000. 105–111. 20 indexed citations

20.

Yang, N. Nora, et al.. (2015). Supplementary Materials for Financing translation: Analysis of the NCATS rare-diseases portfolio. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact